Watchlist Price Alert

Tandem Diabetes Care Inc. (TNDM)

NASDAQ: TNDM · Real-Time Price · USD

20.23

-0.18 (-0.86%)

At close: Jun 20, 2025, 3:59 PM

20.55

1.58%

After-hours: Jun 20, 2025, 05:08 PM EDT

-0.86% (1D)

Bid	20
Market Cap	1.35B
Revenue (ttm)	1.1B
Net Income (ttm)	-183.87M
EPS (ttm)	-2.79
PE Ratio (ttm)	-7.25
Forward PE	-31.88
Analyst	Hold

Ask	21.37
Volume	694,096
Avg. Volume (20D)	1,498,193
Open	20.69
Previous Close	20.41
Day's Range	20.05 - 20.91
52-Week Range	15.75 - 48.24
Beta	1.52

About TNDM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol TNDM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TNDM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Tandem Diabetes Care Inc. is scheduled to release its earnings on Jul 31, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+18.58%

Tandem Diabetes shares are trading higher after th... Unlock content with Pro Subscription

2 months ago

-2.32%

Shares of diabetes stocks are trading lower following successful obesity data from Lilly.

News

1 day ago · businesswire.com

Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump...

1 week ago · businesswire.com

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced an agreement to develop and commercialize integrated ...

3 weeks ago · zacks.com

Tandem Diabetes Care (TNDM) Up 6.5% Since Last Earnings Report: Can It Continue?

Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock?

1 month ago · zacks.com

Should Tandem Diabetes Stock Stay in Your Portfolio Now?

Investors remain optimistic about TNDM, courtesy of its strong t:slim X2 performance and breakthrough innovations.

1 month ago · zacks.com

TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up

Tandem Diabetes' Q1 bottom line lags estimate. However, the company experiences strong sales growth both in and outside the United States.

1 month ago · seekingalpha.com

Tandem Diabetes Care, Inc. (TNDM) Q1 2025 Earnings Conference Call Transcript

Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Susan Morrison - EVP & Chief Administrative Officer John Sheridan - President ...

1 month ago · zacks.com

Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with...

1 month ago · zacks.com

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss of $0.63 per share a year ago.